Researchers at the University of California, Davis have identified a genetic discovery associated with the physical conformation and gait performance in horses.

Researchers at the University of California, Davis, have developed a 3D-printed implant for dogs and cats for treating TMJ ankylosis. The device can accommodate any sized animal and is produced with biocompatible materials with high stress/strain resistance.

Researchers at the University of California, Davis have developed agents made from terpenoids and salicylates that can be used as anesthetics in human and non-human animals, as well as environmentally friendly euthanasia agents in food-producing animals.

Researchers at the University of California, Davis have developed a method of treating infections caused by Clostridium perfringens bacteria - via inhibiting the bacteria’s normal quorum sensing processes.

Researchers at the University of California, Davis have developed a system to assess, estimate and devise a comprehensive control and prevention plan for bovine respiratory disease in pre-weaned dairy calves.

Researchers at the University of California, Davis have developed adjunctive therapies applicable to multiple types of infectious conditions. These therapies – derived from compounds found in natural herbs - also have potential prophylactic efficacy.

Researchers at the University of California, Davis have developed a protocol and assay to assess the rate of metabolism of vitamin E in horses that serves as a potential diagnostic test for equine neuroaxonal dystrophy (eNAD) and equine degenerative myeloencephalopathy (EDM).

Researchers at the University of California, Davis have developed a biologic treatment for mitigating pain and treating acute urinary tract infections (UTIs) in canines.

Researchers at the University of California, Davis have developed monoclonal antibodies with multiple applications relevant to canine PD-1 and PD-L1.

Researchers at the University of California, Davis have developed a program based on machine learning algorithms to aid in diagnosing hypoadrenocorticism.

Researchers at the University of California, Davis have developed a method of detecting canine left atrial enlargement as an early sign of mitral valve disease by applying machine learning techniques to thoracic radiograph images.

Researchers at the University of California, Davis, have developed a diagnostic method to identify dogs that are at risk for chondrodystrophy and/or intervertebral disc disease.

Researchers at the University of California, Davis have cultured a titi monkey adenovirus (TMAdV,) and used the virus to develop a model of human respiratory disease.

Researchers at the University of California, Davis have developed a new and simple, label-free method to detect milligram levels of RNase activity in undiluted biological samples that is selective, accurate and scalable.

Researchers at the University of California, Davis have discovered a new signal pathway involved in depression. This could be a potential target of pharmacological treatment of central nervous system disease and specially depression in man and companion animals. The technology could be best practiced with soluble epoxide hydrolase inhibitors, which have high oral bioavailability, good pharmacokinetics, picomolar potency, low toxicity and CNS activity.

Researchers at the University of California, Davis have developed a method of delivering targeted bioactives that is applicable to the agricultural, food processing, cosmetic, veterinary and medical industries.

Carrier Tests for Point-Restriction and Albinism in the Domestic Cat

DNA Mutation Tests for PKD in domestic cats.

Assay for an Informative SNP used to Identify Carriers of the HERDA Disease Allele ****U.S. PATENT NO. 7,608,400 ISSUED OCTOBER 27, 2009****

Identification of Mutations in the Gene CMAH that causes the Cat Blood Type B

Isolated Novel Feline Calicivirus hFCV for Detecting and Preventing Infection